Catalyst Pharmaceuticals, Inc. - Common Stock (NQ:CPRX)Price and VolumeDetailed Quote
Top NewsMore NewsPerformance
52-Week Range
3.3% below 52-week high
31.49
20.3252W Low
32.5652W High
Catalyst Pharmaceuticals, Inc. - Common Stock (CPRX) traded between $20.32 and $32.56 over the past 52 weeks and last traded at $31.49, 3.3% below its 52-week high.
Past 12 Months
N/A
N/A
N/A
1W
1M
3M
6M
+$5.42
YTD
+$8.34
1Y
+$10.48
CPRX was +49.9% over the past year, +20.8% over six months, +36.0% year to date.
12 Months vs Market
CPRX
DIA
SPY
QQQ
IWM
Over the past 12 months CPRX returned +49.9% versus DIA (Dow) +11.1%, SPY (S&P 500) +14.2%, QQQ (Nasdaq 100) +17.5% and IWM (Russell 2000) +9.3%.
Volume & Liquidity
6M
YTD
1Y
More NewsRead MoreFrequently Asked QuestionsIs Catalyst Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Catalyst Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Catalyst Pharmaceuticals, Inc. - Common Stock trade on?
Catalyst Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Catalyst Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Catalyst Pharmaceuticals, Inc. - Common Stock is CPRX on the Nasdaq Stock Market
What is the current price of Catalyst Pharmaceuticals, Inc. - Common Stock?
The current price of Catalyst Pharmaceuticals, Inc. - Common Stock is 31.49
When was Catalyst Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Catalyst Pharmaceuticals, Inc. - Common Stock was at 07/14/26 04:00 PM ET
What is the market capitalization of Catalyst Pharmaceuticals, Inc. - Common Stock?
The market capitalization of Catalyst Pharmaceuticals, Inc. - Common Stock is 3.24B
How many shares of Catalyst Pharmaceuticals, Inc. - Common Stock are outstanding?
Catalyst Pharmaceuticals, Inc. - Common Stock has 3B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
|
| ||||||||||||||||||||||||
